1SHUI QING YE, TERA LAVOIE, DAVID C USHER, LI Q. ZHANG1 Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, School of Medicine, Baltimore, MD 21224, USA2Department of Biological Science, University of Delaware, Newark, DE 19716, USA.Microarray,SAGE and their applications to cardiovascular diseases[J].Cell Research,2002,12(2):105-115. 被引量：5
5[4]Hoving S, Munchbach M, Schmid H, et al. A method for the chemical generation of N-terminal peptide sequence tags for rapid protein identification[J]. Anal Chem, 2000, 72:1006-1014.
6[5]Dunn MJ. Studying heart disease using the proteomic approach[J]. Drug Discov Today, 2000, 5:76-84.
7[6]Banks RE, Dunn MJ, Hochstrasser DF, et al. Proteomics: new perspectives, new biomedical opportunities[J]. Lancet, 2000, 356:1749 -1756.
8[7]D. Kent Arrell, Irina Neverova, Jennifer E,et al. Cardiovascular Proteomics Evolution and Potential[J]. Circ Res , 2001, 88:763-773.
9[8]Vondriska TM, Klein JB. Use of functional proteomics to investigate PKCε-mediated cardioprotection:the signaling module hypothesis[J]. Am J Physiol Heart Circ Physiol, 2001, 280:H1434-H1441,
10[9]Macri J, McGee B, Thomas JN, et al.Cardiac sarcoplasmic reticulum and sarcolemmal proteins separated by twodimensional electrophoresis: surfactant effects on membrane solubilization[J]. Electrophoresis, 2000b, 21:1685-1693.
10Richard A,James R, David D, et al. The association of hypertension and secondary cardiovascular disease with sleep disordered breathing. Chest, 2003,123 : 244-260.
